October 15, 2025

Prevalence of Endocrinopathies in Beta Thalassemia Major Patients attending Al-Faihaa Specialized Endocrine Center at Al-Basra City

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective study finds 95.9% prevalence of endocrinopathies in beta thalassemia major patients, indicating significant health impacts.

Endocrinopathies were prevalent in 95.9% of beta thalassemia major patients, demonstrating a critical complication.
Common endocrine disorders included growth hormone deficiency and secondary hypoparathyroidism, impacting many patients.
This retrospective descriptive cross-sectional study analyzed data from 172 beta thalassemia major patients at a specialized center.
Older age and longer disease duration were found significant risk factors for the higher prevalence of endocrine disorders.

Hamdi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark